World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
47
Citations
15468
World Ranking
2709
National Ranking
1311

Thomas F. Westbrook publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Thomas F. Westbrook sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 79 publications — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Thomas F. Westbrook D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas F. Westbrook sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 47 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Thomas F. Westbrook is affiliated with Baylor College of Medicine in the United States. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, with a significant focus also on Medicine. Within these broader areas, the scientist has contributed extensively to subfields including Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cell Biology, and Cancer Research.

The topics frequently addressed in Westbrook's work include RNA modifications and cancer, Epigenetics and DNA Methylation, Ubiquitin and proteasome pathways, Microtubule and mitosis dynamics, Cancer-related gene regulation, Protein Degradation and Inhibitors, and Cancer-related Molecular Pathways.

Westbrook's recent scholarly output features multiple publications across highly regarded journals. Selected papers include:

  • Energy-stress-mediated AMPK activation inhibits ferroptosis (2020) published in Nature Cell Biology
  • Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy (2020) published in Cell
  • Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer (2021) published in Cell
  • Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer (2021) published in Molecular Cell
  • ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma (2021) published in Cancer Discovery

Frequent coauthors collaborating with Westbrook include Siddhartha Tyagi, Wesley L. Cai, Don X. Nguyen, Jitendra K. Meena, and Elizabeth A. Bowling. These partnerships have contributed to multiple projects and publications in cancer biology and molecular research.

The scientist has published frequently in major venues such as Cell, Cancer Discovery, Cancer Research, bioRxiv (Cold Spring Harbor Laboratory), and Nature Cell Biology. These outlets reflect the interdisciplinary nature and high impact orientation of the research.

Best Publications

  • A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene

    Ji Luo;Michael J. Emanuele;Danan Li;Chad J. Creighton

  • A resource for large-scale RNA-interference-based screens in mammals

    Patrick J. Paddison;Jose M. Silva;Douglas S. Conklin;Douglas S. Conklin;Mike Schlabach;Mike Schlabach

  • Energy-stress-mediated AMPK activation inhibits ferroptosis.

    Hyemin Lee;Fereshteh Zandkarimi;Yilei Zhang;Jitendra Kumar Meena

  • Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.

    David J. Clark;Saravana M. Dhanasekaran;Francesca Petralia;Jianbo Pan

  • The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo

    Kristen L. Meerbrey;Guang Hu;Jessica D. Kessler;Kevin Roarty

  • A Genetic Screen for Candidate Tumor Suppressors Identifies REST

    Thomas F. Westbrook;Eric S. Martin;Michael R. Schlabach;Yumei Leng

  • A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations

    Yiqun Zhang;Patrick Kwok-Shing Ng;Melanie Kucherlapati;Fengju Chen

  • The spliceosome is a therapeutic vulnerability in MYC-driven cancer

    Tiffany Y.T. Hsu;Lukas M. Simon;Nicholas J. Neill;Richard Marcotte

  • A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.

    Jessica D. Kessler;Kristopher T. Kahle;Kristopher T. Kahle;Tingting Sun;Kristen L. Meerbrey

  • Cancer Proliferation Gene Discovery Through Functional Genomics

    Michael R. Schlabach;Ji Luo;Nicole L. Solimini;Guang Hu

  • MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis

    Atsushi Terunuma;Nagireddy Putluri;Prachi Mishra;Ewy A. Mathé

  • The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells.

    Hai Wang;Cuijuan Yu;Xia Gao;Thomas Welte

  • Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.

    Karsten Krug;Eric J. Jaehnig;Shankha Satpathy;Lili Blumenberg

  • An animal model of MYC-driven medulloblastoma.

    Yanxin Pei;Colin E. Moore;Jun Wang;Alok K. Tewari

  • Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma

    Chen Huang;Lijun Chen;Sara R. Savage;Rodrigo Vargas Eguez

  • SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation.

    Thomas F. Westbrook;Thomas F. Westbrook;Guang Hu;Xiaolu L. Ang;Peter Mulligan

  • Proteogenomic Characterization of Endometrial Carcinoma.

    Yongchao Dou;Emily A. Kawaler;Daniel Cui Zhou;Marina A. Gritsenko

  • Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms.

    Ik Sun Kim;Yang Gao;Thomas Welte;Hai Wang

  • Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.

    Tingting Sun;Nicola Aceto;Kristen L. Meerbrey;Jessica D. Kessler

  • Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma.

    Rhamy Zeid;Matthew A. Lawlor;Evon Poon;Jaime M. Reyes

Frequent Co-Authors

Stephen J. Elledge
Stephen J. Elledge Harvard University
Chad A. Shaw
Chad A. Shaw Baylor College of Medicine
Rachel Schiff
Rachel Schiff Baylor College of Medicine
Chad J. Creighton
Chad J. Creighton Baylor College of Medicine
Jeffrey M. Rosen
Jeffrey M. Rosen Baylor College of Medicine
Juan Botas
Juan Botas Baylor College of Medicine
Michael T. Lewis
Michael T. Lewis Baylor College of Medicine
Susan G. Hilsenbeck
Susan G. Hilsenbeck Baylor College of Medicine
C. Kent Osborne
C. Kent Osborne Baylor College of Medicine
Maciej Wiznerowicz
Maciej Wiznerowicz Poznan University of Medical Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Molecular Biology can open doors to diverse fields within healthcare, research, and even education. Many students interested in life sciences also consider expanding their expertise through flexible online programs. For example, earning a clinical psychology degree online can help individuals apply knowledge of biology to mental health and behavioral sciences.

If you are interested in community work or social support systems, an online human services degree provides foundational skills for roles in counseling, case management, and advocacy. Meanwhile, educators with a biology background may choose to advance their careers by learning teacher to speech pathologist pathways, which blend communication sciences with biological knowledge.

Additionally, those interested in designing science labs or medical facilities may benefit from pursuing an architecture degree online. Each pathway offers unique opportunities for applying molecular biology skills in new and impactful ways.

Best Scientists Citing Thomas F. Westbrook

Trending Scientists